← Holdings
BIO-B

Bio-Rad Laboratories, Inc. Class A

3 managers · $80M total
Data: SEC EDGAR 13F · 2026Q1
Manager holders · last 4 qtrs
3
2025Q2 – 2026Q1 · flat QoQ
Total position
$80M
Combined value across tracked managers
Net move this quarter
↓ Trimming
Weighted by holders' share change
HolderQ actionValue% of port.Style
SoutheasternTrim-28.48%$45M2.23%Deep value / Concentrated
HoskingAdd+27.87%$19M0.69%Contrarian value / Global diversified
MarathonAdd+13.47%$15M0.57%Capital cycle / Contrarian value
Earnings Calls

No earnings call data yet

FinancialsFY2025 · Source: SEC EDGAR 10-K

5y revenue CAGR -3% · latest net margin 29.4% · FCF consistently positive

Revenue$2.58B
Rev. YoY+0.7%
Gross margin51.9%
Net margin29.4%
Net income$0.76B
Free cash flow$0.37B
Operating cash flow$0.53B
ROE10.2%

Source: SEC EDGAR company filings (10-K). Foreign issuers (20-F/IFRS) not yet covered.